Sign in
Explore the registryTrack Tirzepatide's trials

STOP KNEE-OA

Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)

TirzepatideOngoingRecruitingPhase 4Open NCT06191848 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…